Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438849 · ClinicalTrials.gov registry record
Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans
A clinical trial of Urinary Incontinence, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- 2,500
- Enrollment target
- 2
- Study locations
NCT05438849: Active study of Urinary Incontinence, sponsored by University of Alabama at Birmingham.
NCT05438849 is a study of Urinary Incontinence that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 2,500 participants, above the 210-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (1090% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05438849, a study of Urinary Incontinence, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The PURSUIT project aims to improve access to evidence-based nonsurgical UI treatment for women Veterans in the Southeast region of the United States using the most effective remote delivery modality. Using cluster randomization, the study will compare two models at the practice level: (1) the use of a practice facilitation toolkit with a mHealth UI modality alone and (2) the practice facilitation toolkit with a mHealth UI model combined with education on clinical pathways for consultation. Patient level outcomes related to UI symptom improvement will be compared. Patient and provider perceptions of factors that could influence future remote UI treatment scalability will also be assessed. All primary care practices will receive practice facilitation with a PURSUIT toolkit that includes (1) 1-2 visits with a practice facilitator; (2) mobile-health or mHealth application training (MAT); 3) online resource hub; and (4) health information technology (HIT) assistance. PURSUIT's future goal is to disseminate the most effective modality for delivering nonsurgical UI treatment for women Veterans nationally within the VHA.
Primary Outcome
This will include measuring changes, over time, in UI diagnoses for women Veterans. These changes will be measured by pulling data on UI ICD-9 and ICD-10 codes collected via the program's clinical data dashboard.
Conditions Studied
Interventions
- BEHAVIORAL Mobile Health Application focused on behavioral treatments to treat urinary incontinence
- COMBINATION_PRODUCT Practice Facilitation
Study Locations (2)
Alabama
- Birmingham VA Healthcare System - Birmingham
Georgia
- Atlanta VA Health Care System - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2026-06 |
What the registry record for NCT05438849 still lists
NCT05438849 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 210-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (1090% higher).
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Mobile Health Application focused on behavioral treatments to treat urinary incontinence is the first listed.
NCT05438849 reports a single indexed study location in Alabama, Georgia.
Frequently Asked Questions
What is clinical trial NCT05438849 about?
NCT05438849 is a clinical study titled "Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans". The PURSUIT project aims to improve access to evidence-based nonsurgical UI treatment for women Veterans in the Southeast region of the United States using the most effective remote delivery modality. Using cluster randomization, the study will compare two models at the practice level: (1) the use o...
What is the current status of trial NCT05438849?
This trial is currently active not recruiting. The enrollment target is 2,500 participants. The study started on 2022-11-01. Estimated completion is 2026-06.
What conditions does trial NCT05438849 study?
This clinical trial studies the following conditions: Urinary Incontinence.
What interventions are being tested in trial NCT05438849?
The interventions under investigation include: Mobile Health Application focused on behavioral treatments to treat urinary incontinence (BEHAVIORAL), Practice Facilitation (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05438849?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05438849 being conducted?
This trial has 2 study locations across Alabama, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05438849's enrollment target sits among peer trials
2,500 1st of 48 higher than 48 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI